95 related articles for article (PubMed ID: 19318372)
21. Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002).
Narahara H; Iishi H; Imamura H; Tsuburaya A; Chin K; Imamoto H; Esaki T; Furukawa H; Hamada C; Sakata Y
Gastric Cancer; 2011 Mar; 14(1):72-80. PubMed ID: 21340666
[TBL] [Abstract][Full Text] [Related]
22. Phase II trial of S-1 plus low-dose cisplatin for unresectable and recurrent gastric cancer (JFMC27-9902 Step2).
Nakata B; Tsuji A; Mitachi Y; Taenaka N; Kamano T; Oikawa K; Onoda N; Kambe M; Takahashi M; Shirasaka T; Morita S; Sakamoto J; Tanaka Y; Saji S; Hirakawa K
Oncology; 2010; 79(5-6):337-42. PubMed ID: 21430401
[TBL] [Abstract][Full Text] [Related]
23. A phase II study of irinotecan with biweekly, low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFIRI) as first line therapy for patients with recurrent or metastatic gastric cancer.
Kim BG; Oh SY; Kwon HC; Lee S; Lee DM; Kim SG; Kim DK; Jang JS; Kim MC; Kim SH; Kim HJ
Am J Clin Oncol; 2010 Jun; 33(3):246-50. PubMed ID: 19770628
[TBL] [Abstract][Full Text] [Related]
24. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.
Koizumi W; Narahara H; Hara T; Takagane A; Akiya T; Takagi M; Miyashita K; Nishizaki T; Kobayashi O; Takiyama W; Toh Y; Nagaie T; Takagi S; Yamamura Y; Yanaoka K; Orita H; Takeuchi M
Lancet Oncol; 2008 Mar; 9(3):215-21. PubMed ID: 18282805
[TBL] [Abstract][Full Text] [Related]
25. Oral fluoropyrimidines (capecitabine or S-1) and cisplatin as first line treatment in elderly patients with advanced gastric cancer: a retrospective study.
Seol YM; Song MK; Choi YJ; Kim GH; Shin HJ; Song GA; Chung JS; Cho GJ
Jpn J Clin Oncol; 2009 Jan; 39(1):43-8. PubMed ID: 18997184
[TBL] [Abstract][Full Text] [Related]
26. [S-1 for gastric cancer-S-1 monotherapy and its progress].
Shitara K; Sakata Y; Kudou T; Munakata M
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():43-51. PubMed ID: 16897971
[TBL] [Abstract][Full Text] [Related]
27. Treatment of gastric cancer in Asia: the missing link.
Nishida T
Lancet Oncol; 2009 Nov; 10(11):1027-8. PubMed ID: 19880057
[No Abstract] [Full Text] [Related]
28. Impacts of fluorouracil-metabolizing enzymes on the outcomes of patients treated with S-1 alone or S-1 plus cisplatin for first-line treatment of advanced gastric cancer.
Koizumi W; Tanabe S; Azuma M; Ishido K; Nishimura K; Sasaki T; Nakatani K; Higuchi K; Nakayama N; Katada C
Int J Cancer; 2010 Jan; 126(1):162-70. PubMed ID: 19588501
[TBL] [Abstract][Full Text] [Related]
29. Randomized phase II trial of first-line treatment with tailored irinotecan and S-1 therapy versus S-1 monotherapy for advanced or recurrent gastric carcinoma (JFMC31-0301).
Komatsu Y; Takahashi Y; Kimura Y; Oda H; Tajima Y; Tamura S; Sakurai J; Wakasugi T; Tatebe S; Takahashi M; Sakata Y; Kitajima M; Sakamoto J; Saji S
Anticancer Drugs; 2011 Jul; 22(6):576-83. PubMed ID: 21512394
[TBL] [Abstract][Full Text] [Related]
30. [Clinical experience of chemotherapy with S-1/CDDP for highly-advanced gastric cancer].
Uchima Y; Kosaka K; Kimura K; Okita Y; Sim JK; Aomatsu N; Hirata K; Lee WH; Lee T; Nishii T; Tei S; Takeuchi K
Gan To Kagaku Ryoho; 2010 Jul; 37(7):1287-90. PubMed ID: 20647711
[TBL] [Abstract][Full Text] [Related]
31. [Therapeutic strategy for type 4 gastric cancer from the clinical oncologist standpoint].
Sasaki T; Koizumi W; Higuchi K; Ishido K; Ae T; Nakatani K; Katada C; Tanabe S; Saigenji K
Gan To Kagaku Ryoho; 2007 Jul; 34(7):988-92. PubMed ID: 17637532
[TBL] [Abstract][Full Text] [Related]
32. A phase II study of biweekly S-1 and paclitaxel (SPA) as first-line chemotherapy in patients with metastatic or advanced gastric cancer.
Jiang H; Qian J; Zhao P; Zhang X; Zheng Y; Mao C; Zheng Y; Chen L; Wang Y; Mou H; Fang W; Teng L; Xu N
Cancer Chemother Pharmacol; 2015 Jul; 76(1):197-203. PubMed ID: 26013324
[TBL] [Abstract][Full Text] [Related]
33. [Second-line chemotherapy in gastric cancer following S-1 with CPT-11 chemotherapy performed as clinical trial].
Inokuchi M; Yamashita T; Yamada H; Kojima K; Sekita Y; Kawano T; Sugihara K
Gan To Kagaku Ryoho; 2007 Jun; 34(6):875-9. PubMed ID: 17565249
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcome of S-1 and cisplatin combination therapy in patients with advanced or recurrent gastric cancer.
Sakaguchi Y; Kabashima A; Okita K; Ojima Y; Yamamura S; Nishizaki T; Tashiro H; Matsusaka T
Gastric Cancer; 2005; 8(2):111-6. PubMed ID: 15864718
[TBL] [Abstract][Full Text] [Related]
35. Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor.
Cui Y; Li Q; Yu Y; Chen Y; Feng Y; Wang Y; Liu T
Cancer Chemother Pharmacol; 2013 Jan; 71(1):145-52. PubMed ID: 23064955
[TBL] [Abstract][Full Text] [Related]
36. Irinotecan monotherapy as third-line treatment for advanced gastric cancer refractory to fluoropyrimidines, platinum, and taxanes.
Nishimura T; Iwasa S; Nagashima K; Okita N; Takashima A; Honma Y; Kato K; Hamaguchi T; Yamada Y; Shimada Y; Boku N
Gastric Cancer; 2017 Jul; 20(4):655-662. PubMed ID: 27858180
[TBL] [Abstract][Full Text] [Related]
37. [A case of recurrent gastric cancer during adjuvant chemotherapy with S-1, treated by S-1 combination chemotherapy].
Shibata N; Eto TA; Asada T; Takaya T; Tanaka S; Shimayama T; Imada S; Futami S; Hidaka H; Chijiiwa K
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1745-8. PubMed ID: 19838040
[TBL] [Abstract][Full Text] [Related]
38. Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II study.
Lenz HJ; Lee FC; Haller DG; Singh D; Benson AB; Strumberg D; Yanagihara R; Yao JC; Phan AT; Ajani JA
Cancer; 2007 Jan; 109(1):33-40. PubMed ID: 17133415
[TBL] [Abstract][Full Text] [Related]
39. [Chemotherapy for patients with advanced/recurrent gastric cancer and the practice at our institute].
Kishimoto T; Imamura H; Furukawa H; Yamamoto K; Tatsuta M
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1682-4. PubMed ID: 16315908
[TBL] [Abstract][Full Text] [Related]
40. [A case of S-1-resistant gastric cancer with multiple bone metastases and disseminated intravascular coagulation--effective treatment by combined chemotherapy with CDDP and CPT-11].
Kitagawa M; Oguro A; Kondo Y; Koh T; Yamasaki J; Nanri M; Nakagawa N
Gan To Kagaku Ryoho; 2010 Jan; 37(1):165-8. PubMed ID: 20087055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
